Resmonics develops digital biomarkers based on state-of-the-art mobile sensing technology. Founded in 2020, Resmonics is backed by investors that include CSS and is headquartered in Zurich.
FOUNDED:
2020
INDUSTRY:
Medical, Medical Device
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
